21 results
8-K
EX-2.1
PFE
Pfizer Inc.
13 Mar 23
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
8:29am
10-K
2020 FY
EX-2.8
PFE
Pfizer Inc.
Annual report
25 Feb 21
1:59pm
10-Q
2020 Q3
EX-2.1
PFE
Pfizer Inc.
Quarterly report
5 Nov 20
4:57pm
8-K
EX-2.1
PFE
Pfizer Inc.
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-2.2
PFE
Pfizer Inc.
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-2.2
ev1pm3h2r8avjnlu
29 Jul 19
Entry into a Material Definitive Agreement
8:32am
8-K
EX-2.1
kku 8aumsovt32d2
29 Jul 19
Entry into a Material Definitive Agreement
8:32am
425
EX-2.1
fyzq 8n2ot4z
29 Jul 19
Business combination disclosure
8:30am
425
EX-2.2
q22otrsrauakg 0xtqa
29 Jul 19
Business combination disclosure
8:30am
SC TO-C
EX-2.1
nrbci2xg2g6v mq
22 Aug 16
Information about tender offer
12:00am
8-K
EX-2.1
4oo6zfr
22 Aug 16
Pfizer To Acquire Medivation
12:00am
425
EX-2.1
golszj f8ehf
24 Nov 15
Business combination disclosure
12:00am
425
EX-2.1
wjfeu99akidgbg5rm8b
23 Nov 15
Business combination disclosure
12:00am
8-K
EX-2.1
w6eadnk
23 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
paf06 btlgqudtpco
6 Feb 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
zvo58jaanql5ho2u
29 Jan 09
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
pvixibivrd7pzshl9kdo
29 Jan 09
Business combination disclosure
12:00am
8-K
EX-2.1
752ki9
16 Jul 02
Other events
12:00am